Cyclotron

Global Medical Cyclotron Market 2020-2024 | Evolving Opportunities with ALCEN and Ebco Industries Ltd. | Technavio

Retrieved on: 
Mercredi, novembre 27, 2019
Medical devices, Health, Particle accelerators, Accelerator physics, Physics, Cyclotron, Nuclear medicine, Physical sciences, Academic disciplines

Technavio has been monitoring the global medical cyclotron market and the market is poised to grow by USD 55.98 million during 2020-2024 at a CAGR of almost 6% during the forecast period.

Key Points: 
  • Technavio has been monitoring the global medical cyclotron market and the market is poised to grow by USD 55.98 million during 2020-2024 at a CAGR of almost 6% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20191127005111/en/
    Technavio has announced its latest market research report titled global medical cyclotron market 2020-2024.
  • (Photo: Business Wire)
    Read the 147-page research report with TOC on "Medical Cyclotron Market Analysis Report by Product (Cyclotron 35 MeV), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2020-2024".
  • In addition, the use of medical cyclotron technology in nuclear medicine is anticipated to further boost the growth of the medical cyclotron market.

Provision CARES Proton Therapy Orlando Announces Arrival of Cyclotron in Hamlin Development

Retrieved on: 
Lundi, novembre 18, 2019
Radiation therapy, Health, Medical physics, Physical sciences, Proton, Proton therapy, Cyclotron, Therapy, PROTON Holdings, Indiana University Health Proton Therapy Center, TRIUMF

The cyclotron generates the proton beam that is used to treat patients through the ProNova SC360 system.Delivery of the cyclotron is a milestone event in the construction of the proton therapy treatment center.

Key Points: 
  • The cyclotron generates the proton beam that is used to treat patients through the ProNova SC360 system.Delivery of the cyclotron is a milestone event in the construction of the proton therapy treatment center.
  • Following installation of the cyclotron, installation, testing and commissioningof the ProNova SC360will continue as the proton therapy center building is completed.
  • The Provision CARES Proton Center is located in the 17-acre Provision CARES Cancer Center in Hamlin and is a member of the Provision CARES Cancer Network .
  • According to the National Association of Proton Therapy , there are currently 35 proton therapy centers in operation.

Cyclotron Group announces expansion to Chicago market with local delivery of its services

Retrieved on: 
Mercredi, octobre 30, 2019
Geography of California, Cities in the United States, Geography of the United States, Particle accelerators, Midwest Airlines, Cyclotron, Chicago, Bahl, CPG, San Francisco

SAN FRANCISCO, Oct. 30, 2019 /PRNewswire-PRWeb/ --West coast-based Cyclotron Group announces its expansion into Chicago to drive more value for Midwest organizations with its leading technology solutions.

Key Points: 
  • SAN FRANCISCO, Oct. 30, 2019 /PRNewswire-PRWeb/ --West coast-based Cyclotron Group announces its expansion into Chicago to drive more value for Midwest organizations with its leading technology solutions.
  • "The Chicago market, in particular, is one we've had our eye on for some time for its diversified manufacturing, finance, and CPG sectors, in addition to its position as a national distribution hub.
  • The opportunities to drive value here are endless and we can't wait to tap that potential in our Midwest engagements," continued Bahl.
  • Cyclotron Group currently employees over 70 associates worldwide and is headquartered in San Francisco.

CNL & TRIUMF Successfully Produce Rare Medical Isotope that Could Revolutionize Fight Against Cancer

Retrieved on: 
Mercredi, octobre 23, 2019
Physical sciences, Natural sciences, Physics, Chemical elements, TRIUMF, Particle accelerators, Nuclear medicine, Cyclotron, Actinium, Prostate cancer, Jonathan Bagger, Francium

Known as targeted alpha therapy, this form of treatment has shown exciting potential in early studies with prostate cancer patients for whom conventional cancer therapies have not worked.

Key Points: 
  • Known as targeted alpha therapy, this form of treatment has shown exciting potential in early studies with prostate cancer patients for whom conventional cancer therapies have not worked.
  • The 520MeV cyclotron at the heart of TRIUMF allows us to produce actinium-225 at a level of purity not possible with smaller cyclotrons, said Dr. Jonathan Bagger, Director of TRIUMF.
  • Canadas long history of scientific excellence at TRIUMF and CNL is a foundation on which we can build new capabilities and opportunities for the future.
  • TRIUMF Innovations provides pathways for businesses to access the expertise and infrastructure at TRIUMF and across the TRIUMF network.

ARTMS/Odense University Hospital to Present Solid Target Gallium-68 Production Record at European Association of Nuclear Medicine

Retrieved on: 
Jeudi, octobre 10, 2019
Biotechnology, Pharmaceutical, Health, Physical sciences, Physics, Particle accelerators, Natural sciences, Medicinal radiochemistry, Cyclotron, Nuclear medicine, Isotope

ARTMS award-winning technology continues to revolutionize the nuclear medicine industry by enabling global access to cyclotron-produced medical isotopes, said Dr. Schaffer.

Key Points: 
  • ARTMS award-winning technology continues to revolutionize the nuclear medicine industry by enabling global access to cyclotron-produced medical isotopes, said Dr. Schaffer.
  • I am excited to present these new data produced on the ARTMS QISTM hardware and target plate system.
  • We are incredibly pleased to demonstrate the 68Ga production record using our QISTM technology, hardware and target plate system, remarked Charles S. Conroy, CEO of ARTMS.
  • For further information or to schedule a meeting, please contact:
    About Department of Nuclear Medicine, Odense University Hospital, Denmark
    Department of Nuclear Medicine is an interdisciplinary clinical department without beds.

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at Sylvester Comprehensive Cancer Center

Retrieved on: 
Mercredi, août 28, 2019
Health, Radiation therapy, Medicine, Medical physics, Proton, Proton therapy, Cancer, Cyclotron, Therapy, Particle accelerator

The cyclotron is aparticle acceleratorand a significant piece of the equipment in the ProBeam proton therapy system.

Key Points: 
  • The cyclotron is aparticle acceleratorand a significant piece of the equipment in the ProBeam proton therapy system.
  • The Varian ProBeam Compact system is the only single room system capable of fully rotational intensity modulated proton therapy (IMPT).
  • For more information on ProBeam and its Compact single-room configuration, visit: www.varian.com/probeamcompact
    At Varian, we envision a world without fear of cancer.
  • Opened in 1973, Sylvester Comprehensive Cancer Center, part of UHealth the University of Miami Health System, is the only NCI-designated Cancer Center in South Florida and serves as the hub for cancer-related research, diagnosis, and treatment at UHealth.

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore

Retrieved on: 
Mardi, mai 14, 2019
Radiation therapy, Medical physics, Physics, Physical sciences, Academic disciplines, Proton, Proton therapy, PROTON Holdings, Cyclotron, Paul Scherrer Institute

The cyclotron is a core piece of equipment in the ProBeam proton therapy system.

Key Points: 
  • The cyclotron is a core piece of equipment in the ProBeam proton therapy system.
  • This installation marks a key milestone for the first proton therapy center in Singapore, ASEAN, Australia and New Zealand.
  • The Varian ProBeam Compact system is a single-room system equipped with a 360-degree gantry for intensity modulated proton therapy (IMPT).
  • "We are proud of our collaboration with Proton Therapy Pte for the installation of the ProBeam Compact proton system cyclotron at this new center," said Kolleen Kennedy, president, Proton Solutions and chief growth officer, Varian.

Cyclotron Group Announces the Appointment of Stephen R. Clark to Spearhead Expanded Microsoft Azure Initiatives

Retrieved on: 
Jeudi, avril 18, 2019
Cloud computing, Digital technology, Computing, Cloud infrastructure, Cloud storage, Microsoft Azure, Particle accelerators, Azure, Cyclotron

SAN FRANCISCO, April 17, 2019 /PRNewswire-PRWeb/ -- Cyclotron Group, a leading technology consultancy today announced it had hired Stephen R. Clark as its new Azure Practice Manager.

Key Points: 
  • SAN FRANCISCO, April 17, 2019 /PRNewswire-PRWeb/ -- Cyclotron Group, a leading technology consultancy today announced it had hired Stephen R. Clark as its new Azure Practice Manager.
  • "There's a great reason that Cyclotron is certified as an Expert MSP (Managed Service Provider) for Microsoft Azure.
  • I plan to grow our leadership in the Azure arena with expanded services and solutions to keep our clients innovating and thriving," continued Clark.
  • Cyclotron Group addresses our clients' toughest challenges by providing hyper-efficient consultation, strategy, digital transformation, technology implementation, and operational frameworks.

Varian Installs Cyclotron for ProBeam Proton Therapy System at Hefei Ion Medical Center in China

Retrieved on: 
Lundi, avril 8, 2019
Radiation therapy, Health sciences, Health, Medical physics, Applied sciences, Proton, Proton therapy, Particle accelerators, Therapy, Cyclotron, Varian Medical Systems

PALO ALTO, Calif. and HEFEI, China, April 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeamproton therapy system atHefei Ion Medical Center (HIMC) in China.

Key Points: 
  • PALO ALTO, Calif. and HEFEI, China, April 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeamproton therapy system atHefei Ion Medical Center (HIMC) in China.
  • Varian's ProBeam system is the first to offer fully-integrated intensity modulated proton therapy (IMPT) to enable more efficient adaptive proton therapy.
  • In combination with the ARIA oncology information system and Eclipsetreatment planning system, the ProBeam system enables an efficient adaptive workflow.
  • "We are excited to have achieved this important milestone by successfully installing the cyclotron for the first ProBeam proton therapy system in China," said Kolleen Kennedy, president, Proton Solutions and chief growth officer, Varian.

Cyclotron Group Launches New Website to Support Expanded Offerings

Retrieved on: 
Mardi, mars 5, 2019
Particle accelerators, Cyclotron, Nuclear medicine, Academic disciplines

SAN FRANCISCO, March 5, 2019 /PRNewswire-PRWeb/ --Cyclotron Group, a leading technology consultancy today announced it had launched a new website to coincide with expanded services and products.

Key Points: 
  • SAN FRANCISCO, March 5, 2019 /PRNewswire-PRWeb/ --Cyclotron Group, a leading technology consultancy today announced it had launched a new website to coincide with expanded services and products.
  • With our unique consultancy approach and our new and expanded services, the timing couldn't be better.
  • Cyclotron Group addresses our clients' toughest challenges by providing hyper-efficient consultation, strategy, digital transformation, technology implementation, and operational frameworks.
  • Headquartered in San Francisco, Cyclotron Group currently employees over 50 associates worldwide.